Boston Scientific (BSX) Amortization of Deferred Charges (2020 - 2026)

Boston Scientific (BSX) has 7 years of Amortization of Deferred Charges data on file, last reported at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges fell 97.53% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $53.0 million (down 59.85% YoY), and the FY2025 full-year result was $132.0 million, up 158.82% from the prior year.
• Amortization of Deferred Charges slipped to $2.0 million in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $81.0 million in Q1 2025 to a low of $2.0 million in Q1 2026.
• A 5-year average of $20.3 million and a median of $8.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges soared 112.5% in 2022 and plunged 97.53% in 2026, its largest moves.
• Tracing BSX's Amortization of Deferred Charges over 5 years: stood at $7.0 million in 2022, then slumped by 57.14% to $3.0 million in 2023, then jumped by 1600.0% to $51.0 million in 2024, then tumbled by 90.2% to $5.0 million in 2025, then tumbled by 60.0% to $2.0 million in 2026.
• Business Quant data shows BSX's Amortization of Deferred Charges at $2.0 million in Q1 2026, $5.0 million in Q4 2025, and $9.0 million in Q3 2025.